HPV Vaccination and Cervical Cancer Screening: The Risk of Partial Prevention

(Epidemiological Anthropology | UPSC Anthropology Paper I)

Introduction

Cervical cancer remains one of India’s most significant public health challenges, accounting for a large share of cancer-related mortality among women. The disease is primarily caused by persistent infection with Human Papillomavirus (HPV)—especially high-risk strains HPV-16 and HPV-18, which contribute to nearly 70% of global cervical cancer cases.

India’s recent push for HPV vaccination among adolescent girls marks a major step towards preventive healthcare. However, an emerging social and behavioural paradox threatens these gains: the belief that vaccination alone eliminates the need for cervical cancer screening.

Core Issue: The Myth of Complete Protection

The central problem lies in a widespread misconception:

HPV vaccination provides lifetime immunity against cervical cancer

This false sense of security has led to reduced participation in Pap smear screening, increasing the risk of delayed detection and preventable deaths.

Scientific Limits of HPV Vaccination

While HPV vaccines are a medical breakthrough, they are not foolproof:

• Protect against common high-risk strains, not all cancer-causing HPV types
   
• Do not clear pre-existing infections
   
• Less effective when administered after sexual debut
   
• Residual risk of cervical cell abnormalities persists even in vaccinated women
   

Thus, vaccination is preventive, not diagnostic.

Role of Pap Smear Screening

Pap smear tests are essential for early detection:

• Detect cellular changes before symptoms appear
   
• Enable simple, minimally invasive, and highly successful treatment
   

Recommended guidelines:

• Pap smear from 21 years of age
   
• Pap smear + HPV DNA testing after 30 years
   

Despite this, only about 1% of Indian women are screened, revealing a severe implementation gap.

Social and Behavioural Challenges

Several anthropological factors limit screening uptake:

• Low awareness and fear of gynaecological tests
   
• Cultural stigma around reproductive health
   
• Over-reliance on vaccination as a “one-time solution”
   
• Urban–rural and socio-economic disparities in access
   

These barriers highlight how health behaviour is socially constructed, not purely medical.

Stakeholders Involved

• Women and adolescent girls
   
• Healthcare providers and gynaecologists
   
• Government health departments
   
• NGOs and public health educators
   
• Families and communities
   

Effective prevention requires coordinated action across all stakeholders.

Ethical and Governance Concerns

• Right to accurate health information: Miscommunication causes avoidable harm
   
• Preventive justice: Benefits must reach all sections equitably
   
• Public trust: Over-promising vaccine benefits risks erosion of confidence
   

Policy and Administrative Solutions

Integrated Prevention Strategy

• HPV vaccination must be coupled with mandatory screening awareness
   
• Clear distinction between prevention and early detection
   

Strengthening Screening Infrastructure

• Expand Pap smear and HPV DNA testing at primary health centres
   
• Scale up indigenous HPV test kits to reduce costs
   

Behaviour Change Communication (BCC)

• Target myths via school curricula, ASHA workers, and digital platforms
   
• Involve families to overcome stigma
   

Monitoring and Evaluation

• Track screening rates among vaccinated cohorts
   
• Link immunisation records with screening reminders
   

Conclusion

Cervical cancer is one of the most preventable cancers—but only when prevention is complete, not partial. HPV vaccination is not a free pass. Without regular screening and follow-up, the promise of elimination remains unfulfilled. From an anthropological lens, sustainable public health outcomes demand scientific clarity, social awareness, and administrative integration—together.